GBM AGILE

GBM AGILE is a flexible research platform designed to speed up the development of treatments for glioblastoma, a serious brain cancer. Instead of testing one drug at a time in separate trials, it allows multiple therapies to be tested simultaneously within the same study. This approach accelerates the identification of effective treatments by adapting quickly based on ongoing results. Ultimately, GBM AGILE aims to find better, personalized options more efficiently, bringing promising therapies to patients faster and improving outcomes for those with this challenging disease.